1. Home
  2. RKDA vs DRMA Comparison

RKDA vs DRMA Comparison

Compare RKDA & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

HOLD

Current Price

$3.66

Market Cap

5.8M

Sector

Industrials

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$2.68

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKDA
DRMA
Founded
2002
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8M
2.1M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
RKDA
DRMA
Price
$3.66
$2.68
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
12.7K
102.5K
Earning Date
11-07-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,173,000.00
N/A
Revenue This Year
$21.31
N/A
Revenue Next Year
$28.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.31
N/A
52 Week Low
$2.53
$2.34
52 Week High
$6.71
$23.70

Technical Indicators

Market Signals
Indicator
RKDA
DRMA
Relative Strength Index (RSI) 46.82 38.67
Support Level $3.58 $2.66
Resistance Level $3.87 $2.98
Average True Range (ATR) 0.19 0.29
MACD 0.01 0.03
Stochastic Oscillator 40.49 35.37

Price Performance

Historical Comparison
RKDA
DRMA

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.

Share on Social Networks: